NCT06063681
A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05047536
KZR-261 in Subjects With Advanced Solid Malignancies No drug interventions treatment 1 active_not_recruiting NCT05914545
A Study of FZ-AD004 in Patients with Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03406871
Regorafenib and Nivolumab Simultaneous Combination Therapy treatment 1 / 2 completed NCT02452268
A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic Cancers treatment 1 terminated NCT03920839
INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105) treatment 1 withdrawn NCT04617522
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment treatment 1 recruiting NCT04999761
AB122 Platform Study treatment 1 recruiting NCT04965077
Treatment of Advanced and Metastatic Solid Tumors With MIL97 No drug interventions treatment 1 recruiting NCT04327583
Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral Therapy No drug interventions supportive_care Not Available recruiting NCT05263986
The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors treatment 1 active_not_recruiting NCT04189445
Futibatinib in Patients With Specific FGFR Aberrations treatment 2 active_not_recruiting NCT06117371
Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation No drug interventions treatment 1 recruiting NCT03517956
Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT06234397
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT06389526
A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors treatment 1 not_yet_recruiting NCT06548217
A Phase I Study of ONO-4538HSC in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05388279
A Clinical Study to Evaluate the Safety and Tolerability of JS012 in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 terminated NCT05787587
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05399654
A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT05598151
Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT03082053
A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours treatment 1 completed NCT00748553
A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast Cancer treatment 1 / 2 completed NCT05678998
WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma No drug interventions treatment 1 recruiting NCT06074497
This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy With Envafolimab in Patients With Advanced or Metastatic Solid Tumors. treatment 1 recruiting NCT03155061
Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT05407909
To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT04843709
A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03665285
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 completed NCT03684785
Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors treatment 1 / 2 terminated NCT03730337
Phase 1 Study of ONO-7475 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors treatment 1 completed NCT02261532
A Phase I Study of TAS-102 in Solid Tumors treatment 1 completed NCT04408599
A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 terminated NCT04866134
A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT01506934
A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors basic_science 1 terminated NCT05483530
A Study to Investigate the Safety, Tolerability and Efficacy of HLX60 Combination With HLX10 in Subjects With Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT05848466
Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients No drug interventions treatment 1 recruiting NCT04427774
A Study of Surufatinib Plus Sintilimab in Patients With Advanced Solid Tumor treatment 1 terminated NCT03616574
First-in-human Study of CA102N Monotherapy and CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjects With Advanced Solid Tumors treatment 1 completed NCT06374173
A Phase 1 Study to Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT01928394
A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors treatment 1 / 2 active_not_recruiting NCT06196762
Phase I of XKH002 Injection in Patients No drug interventions treatment 1 not_yet_recruiting NCT01014429
Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors treatment 1 completed NCT05693844
Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors treatment 1 / 2 recruiting NCT05907304
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations treatment 1 recruiting NCT05017012
A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of MK-3475A (Pembrolizumab Formulated With MK-5180) In Advanced Solid Tumors (MK-3475A-C18) treatment 1 active_not_recruiting NCT05957081
Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309 treatment 1 not_yet_recruiting NCT05716295
A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 terminated NCT05652855
Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT03316638
A Study of a New Investigational Medicinal Product to Treat Patients With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT03248843
A Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT03454243
Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 0 terminated NCT06448364
A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination treatment 1 active_not_recruiting NCT01355302
E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer treatment 1 / 2 terminated NCT05572684
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT04670679
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT04430933
A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC treatment 1 / 2 withdrawn NCT05785754
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT00907205
A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors treatment 1 completed NCT06248411
A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT04572152
A Study of AK119 (Anti-CD73) in Combination With AK104 in Subjects With Advanced Solid Tumors treatment 1 active_not_recruiting NCT04586270
A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer No drug interventions treatment 1 recruiting NCT04875806
A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 terminated NCT02220049
Dose Escalation of Velcade Daily Dose in Patients With Solid Tumors treatment 1 completed NCT00276913
A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 recruiting NCT06257758
A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05753722
A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies treatment 1 recruiting NCT05382325
A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001) treatment 1 active_not_recruiting NCT02004548
Phase I Clinical Study of Metatinib Tromethamine Tablet treatment 1 completed NCT05200273
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114 No drug interventions treatment 1 unknown_status NCT03849469
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors treatment 1 completed NCT05496595
DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 terminated NCT04381650
A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors treatment 1 / 2 active_not_recruiting NCT04003623
Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208) treatment 2 terminated NCT05594043
A Study of MK-6598 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-6598-001) treatment 1 recruiting NCT05425602
A Study of MAX-40279combined With KN046 in Patients With Advanced / Metastatic Solid Tumors treatment 1 / 2 not_yet_recruiting NCT05174637
A Study of FDA018-ADC in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02444793
A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors treatment 1 terminated NCT04182516
Study of NMS-03305293 in Pts With Selected Advanced/Metastatic Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02665416
Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid Tumors treatment 1 completed NCT05614258
Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT04501276
A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients No drug interventions treatment 1 active_not_recruiting NCT05514444
Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001) treatment 1 active_not_recruiting NCT05394168
A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04645069
ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors No drug interventions treatment 1 / 2 completed NCT05405595
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors treatment 1 / 2 recruiting NCT05277402
ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors treatment 1 completed NCT05607498
First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma No drug interventions treatment 1 recruiting NCT01092052
Study of NMS-1116354 in Advanced/Metastatic Solid Tumors No drug interventions treatment 1 terminated NCT03833427
Study of Selumetinib (MK-5618) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (MK-5618-001) treatment 1 completed NCT05718895
A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT00996255
Dose-Escalation Study of PHA-793887 in Patients With Advanced/Metastatic Solid Tumors treatment 1 terminated